What does Apotheek Ann Hendrix do?

Apotheek Ann Hendrix is a pharmacy in Boortmeerbeek. Private Limited, started on 24 December 2014, 1 establishment.

What is the address of Apotheek Ann Hendrix?

The registered office of Apotheek Ann Hendrix is located at Leuvensesteenweg 22, 3190 Boortmeerbeek.

Is Apotheek Ann Hendrix still active?

Yes. According to the CBE (30 October 2026) Apotheek Ann Hendrix is active, legal situation “Normale toestand”, started on 24 December 2014.

Is Apotheek Ann Hendrix registered on Peppol?

Yes, Apotheek Ann Hendrix is registered on the Peppol network with ID 0208:0507732642.

What is the enterprise number of Apotheek Ann Hendrix?

The enterprise number of Apotheek Ann Hendrix is BE0507732642.

When was Apotheek Ann Hendrix founded?

Apotheek Ann Hendrix was founded on 24 December 2014.

Who are the directors of Apotheek Ann Hendrix?

According to the 2025 annual accounts, the directors of Apotheek Ann Hendrix are: Ann Hendrix, Antoon Medaer.

Is Apotheek Ann Hendrix a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 December 2014; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Apotheek Ann Hendrix make in 2025?

Apotheek Ann Hendrix recorded a loss after taxes of € 5,254 in financial year 2025.

What is the revenue of Apotheek Ann Hendrix?

As a small company, Apotheek Ann Hendrix is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 90,665.

Does Apotheek Ann Hendrix have a website?

Yes, Apotheek Ann Hendrix has a website at pharmapoint.be.

Apotheek Ann Hendrix (Private Limited) - Boortmeerbeek

Dossier Apotheek Ann Hendrix, printed on 30 October 2026 from databakkes.be/en/0507732642/apotheek-ann-hendrix. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Tight liquidity NBB

Cash and receivables cover 39 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Apotheek Ann Hendrix from Boortmeerbeek, company number BE0507732642, closed financial year 2025 with a result of € -5,254 after tax. For that financial year Apotheek Ann Hendrix recorded a gross margin of € 90,665 and equity of € -15,521. Compared with financial year 2024, the result moved from € 11,880 to € -5,254. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 12, 2026.

What it is worth Caution

€ -15,521

▼ € 5,254 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -5,254

▼ still € 11,880 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 2,140

▼ 33% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -34,121.

People and assets in 2025

Wage cost

€ 53,052

▲ 262% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 2,560

▼ 39% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 330,627

▼ 11% vs 2024

€ 45,071 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 91,597

▲ 102% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 1,355

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 156,981 Gross margin 2022: € 156,981 First fiscal year in the series	€ 157,630 Gross margin 2023: € 157,630 Unchanged (€ 156,981) Favourable step	€ 96,588 Gross margin 2024: € 96,588 ▼ 39% vs 2023 (€ 157,630) Unfavourable step	€ 90,665 Gross margin 2025: € 90,665 ▼ 6% vs 2024 (€ 96,588) Unfavourable step	▼ 6%
Profit after taxes	€ 26,487 Profit after taxes 2022: € 26,487 First fiscal year in the series	€ 9,562 Profit after taxes 2023: € 9,562 ▼ 64% vs 2022 (€ 26,487) Unfavourable step	€ 11,880 Profit after taxes 2024: € 11,880 ▲ 24% vs 2023 (€ 9,562) Favourable step	€ -5,254 Profit after taxes 2025: € -5,254 ▼ € 17,134 vs 2024 (€ 11,880) Unfavourable step	▼ € 17,134
Equity	€ -31,709 Equity 2022: € -31,709 First fiscal year in the series	€ -22,147 Equity 2023: € -22,147 ▲ € 9,562 vs 2022 (€ -31,709) Favourable step	€ -10,267 Equity 2024: € -10,267 ▲ € 11,880 vs 2023 (€ -22,147) Favourable step	€ -15,521 Equity 2025: € -15,521 ▼ € 5,254 vs 2024 (€ -10,267) Unfavourable step	▼ € 5,254
Total debts	€ 520,818 Total debts 2022: € 520,818 First fiscal year in the series	€ 521,947 Total debts 2023: € 521,947 Unchanged (€ 520,818) Unfavourable step	€ 483,324 Total debts 2024: € 483,324 ▼ 7% vs 2023 (€ 521,947) Favourable step	€ 492,998 Total debts 2025: € 492,998 ▲ 2% vs 2024 (€ 483,324) Unfavourable step	▲ 2%
Cash	€ 40,496 Cash 2022: € 40,496 First fiscal year in the series	€ 12,939 Cash 2023: € 12,939 ▼ 68% vs 2022 (€ 40,496) Unfavourable step	€ 3,214 Cash 2024: € 3,214 ▼ 75% vs 2023 (€ 12,939) Unfavourable step	€ 2,140 Cash 2025: € 2,140 ▼ 33% vs 2024 (€ 3,214) Unfavourable step	▼ 33%
Land & buildings	€ 288,473 Land & buildings 2022: € 288,473 First fiscal year in the series	€ 256,945 Land & buildings 2023: € 256,945 ▼ 11% vs 2022 (€ 288,473) Unchanged	€ 225,416 Land & buildings 2024: € 225,416 ▼ 12% vs 2023 (€ 256,945) Unchanged	€ 216,970 Land & buildings 2025: € 216,970 ▼ 4% vs 2024 (€ 225,416) Unchanged	▼ 4%
Retained profit	€ -50,309 Retained profit 2022: € -50,309 First fiscal year in the series	€ -40,747 Retained profit 2023: € -40,747 ▲ € 9,562 vs 2022 (€ -50,309) Favourable step	€ -28,867 Retained profit 2024: € -28,867 ▲ € 11,880 vs 2023 (€ -40,747) Favourable step	€ -34,121 Retained profit 2025: € -34,121 ▼ € 5,254 vs 2024 (€ -28,867) Unfavourable step	▼ € 5,254
Bank debt	€ 390,482 Bank debt 2022: € 390,482 First fiscal year in the series	€ 384,332 Bank debt 2023: € 384,332 ▼ 2% vs 2022 (€ 390,482) Favourable step	€ 370,854 Bank debt 2024: € 370,854 ▼ 4% vs 2023 (€ 384,332) Favourable step	€ 330,627 Bank debt 2025: € 330,627 ▼ 11% vs 2024 (€ 370,854) Favourable step	▼ 11%
Balance sheet total	€ 489,109 Balance sheet total 2022: € 489,109 First fiscal year in the series	€ 499,799 Balance sheet total 2023: € 499,799 ▲ 2% vs 2022 (€ 489,109) Unchanged	€ 473,057 Balance sheet total 2024: € 473,057 ▼ 5% vs 2023 (€ 499,799) Unchanged	€ 477,477 Balance sheet total 2025: € 477,477 ▲ 1% vs 2024 (€ 473,057) Unchanged	▲ 1%

Key figures of Apotheek Ann Hendrix, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Ann Hendrix?

What happened at Apotheek Ann Hendrix in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 12, 2026 New annual accounts for financial year 2025: loss of € 5,254 (▼ € 17,134 vs 2024). Source: NBB ↗
Dec 24, 2014 New establishment in Boortmeerbeek. KBO
Dec 24, 2014 Start of the company according to the CBE. KBO

In short

From € 26,487 profit in 2022 to € 5,254 loss in 2025.

Best year ever: 2022, with € 26,487 profit.

Original PDFs at the National Bank ↗

Management

Ann Hendrix Antoon Medaer

PHARMAPOINT

MEDIPHARMA

Apotheek Ann Hendrix

Behind Apotheek Ann Hendrix are Ann Hendrix and Antoon Medaer. The same people are also behind MEDIPHARMA. Ann Hendrix is also behind PHARMAPOINT.

Directors

According to the 2025 annual accounts

Ann Hendrix

Bestuurder

Also active at: PHARMAPOINT, MEDIPHARMA

Antoon Medaer

Bestuurder

Also active at: MEDIPHARMA

Establishments

Establishment units

Physical locations of this company

Registered office

Leuvensesteenweg 22

3190 Boortmeerbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS pharmapoint.be

Technologies

ApacheBootstrapChart.jsDiviElementorFont AwesomeGoogle FontsOwl CarouselPHPSwiperWP RocketWPMLWooCommerceWordPressYoast SEOjQueryjQuery UIlazysizesreCAPTCHA

Hosting & Email

Email provider

one.com Mail

Hosting

A2HOSTING - A2 Hosting, Inc., US

Website info

HTTPS Ja

Languages EN

Features

Webshop Blog Contact page

Security

✓ HTTPS

✗ SPF

✗ DMARC

Details

Company number: 0507.732.642
VAT number: BE 0507.732.642
Registered office: Leuvensesteenweg 22, 3190 Boortmeerbeek
Names & denominations: Apotheek Ann Hendrix
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 December 2014
Peppol: Active · Active since 24 Nov 2023
Contact: pharmapoint.be
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗